Literature DB >> 17882224

Novel mutations in a Japanese patient with CD19 deficiency.

H Kanegane1, K Agematsu, T Futatani, M M Sira, K Suga, T Sekiguchi, M C van Zelm, T Miyawaki.   

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by recurrent bacterial infections, hypogammaglobulinemia and low to normal numbers of circulating B cells. Mutations in the ICOS, TACI and CD19 genes have recently been identified in <10% of CVID patients. We, herein, describe two novel CD19 gene disruptions in an 8-year-old Japanese boy, who had been clinically diagnosed as having CVID at the age of 5 years. Flow-cytometric analysis demonstrated absence of CD19 and reduced CD21 expression on CD20-postive peripheral blood B cells. Mutation analysis of CD19 revealed a mutation in the splice acceptor site of intron 5 (IVS5-1G>T) of the maternal allele, resulting in skipping of exon 6, and a truncated protein product. The paternal allele was disrupted by a gross deletion encompassing at least the ATP2A1, CD19 and NFATC2IP genes. The patient had a small number of IgD(-) CD27(+) memory B cells, in which somatic mutation were detected. His B cells showed substantial proliferation upon stimulation, but reduced IgG and IgA production in vitro. These findings extend the mutation spectrum of the CD19 deficiency to four, and confirm the homogeneity of the CD19 deficiency as a unique type of CVID.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17882224     DOI: 10.1038/sj.gene.6364431

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  42 in total

Review 1.  Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.

Authors:  Katharine S Nelson; David B Lewis
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

2.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

3.  IgH sequences in common variable immune deficiency reveal altered B cell development and selection.

Authors:  Krishna M Roskin; Noa Simchoni; Yi Liu; Ji-Yeun Lee; Katie Seo; Ramona A Hoh; Tho Pham; Joon H Park; David Furman; Cornelia L Dekker; Mark M Davis; Judith A James; Kari C Nadeau; Charlotte Cunningham-Rundles; Scott D Boyd
Journal:  Sci Transl Med       Date:  2015-08-26       Impact factor: 17.956

4.  Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency.

Authors:  Claire Rivoisy; Laurence Gérard; David Boutboul; Marion Malphettes; Claire Fieschi; Isabelle Durieu; François Tron; Agathe Masseau; Pierre Bordigoni; Laurent Alric; Julien Haroche; Cyrille Hoarau; Alice Bérézné; Maryvonnick Carmagnat; Gael Mouillot; Eric Oksenhendler
Journal:  J Clin Immunol       Date:  2011-10-15       Impact factor: 8.317

Review 5.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

6.  Genome-wide association identifies diverse causes of common variable immunodeficiency.

Authors:  Jordan S Orange; Joseph T Glessner; Elena Resnick; Kathleen E Sullivan; Mary Lucas; Berne Ferry; Cecilia E Kim; Cuiping Hou; Fengxiang Wang; Rosetta Chiavacci; Subra Kugathasan; John W Sleasman; Robert Baldassano; Elena E Perez; Helen Chapel; Charlotte Cunningham-Rundles; Hakon Hakonarson
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

7.  Role of B cells in common variable immune deficiency.

Authors:  Sam Ahn; Charlotte Cunningham-Rundles
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

Review 8.  Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin's lymphomas.

Authors:  Tam Nm Dinh; Alexandra S Onea; Ali R Jazirehi
Journal:  Am J Clin Exp Immunol       Date:  2017-05-15

9.  Reduced CD19 expression and decreased memory B cell numbers in transient hypogammaglobulinemia of infancy.

Authors:  Hasibe Artac; Reyhan Kara; Bahar Gokturk; Ismail Reisli
Journal:  Clin Exp Med       Date:  2012-07-21       Impact factor: 3.984

10.  TACI mutations and disease susceptibility in patients with common variable immunodeficiency.

Authors:  A E J Poodt; G J A Driessen; A de Klein; J J M van Dongen; M van der Burg; E de Vries
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.